HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Strategic Partners
Lorraine Boyle
Dominika Dabrowski
Stephen Filbey
Brent Korte
Careers
SERVICES
Our Services
Strategic Advice
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report (CRaFT)
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
pERC
All the posts published.
Numbers Steady after Limited September Outputs from pCPA and CADTH
October 16, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
An Uncharacteristically Slow August Gives Way to an Uncertain Fall
September 17, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Impact of COVID19 on pCPA Negotiations Starting to Emerge
August 13, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Some Positive Indicators as Number of Files Under Consideration Remains Flat – June 2020
July 28, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
No Files Completed or Closed by the pCPA – May 2020
June 23, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Early Insights into pCPA Prioritization
May 22, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Summary of CADTH Pharmaceutical Reviews Update – Issue 15
May 6, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
New pCPA Website & Available Data
April 7, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
pCPA – The Beginning of a Period of Uncertainty?
March 27, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
pCPA Closing in on 300 Completed Negotiations
February 13, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
A Busy 2019 ends with a quiet December
January 10, 2020
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Number of active negotiations (34) at lowest point since March 2017
December 6, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Summary of the CADTH Drug Portfolio Information Session November 2019
December 2, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
The workload at pCPA appears to have stabilized over 2019
November 14, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Average Time Under pCPA Consideration Below 30 Days for the 3rd Consecutive Month
October 16, 2019
-
Market Access News
-
Posted by
MORSE
Read More →
Read More →
Older posts
Newer posts
pERC - Info and details on - Page 2 of 3 - MORSE Consulting Inc.
Private
Public
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Public
Private
Public
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB
Private
INESSS
CADTH
HTA
pCPA
Public Payers
Health Canada
Patients
Private Payers
PMPRB